The Millionaires Club A forum where gentlepersons may discuss finance and related matters
wit is appreciated - vulgarity is not

Introduction

View Introduction

Archives

View Archives

Search Archives

Info

Adding Images

Adding Links

Links

 aaa Brown attacked by M|EP

 aaa The Great GW Circus

 ADVFN

 AIM

 Barclays Stockbrokers

 BBC

 Bloomberg

 Bullion Desk

 CMC

 CNN

 Companies House

 CSY Computer Systems

 Daily Bayonet

 Dailyfx

 Digital Look

 Fark

 French Property

 FT.com

 Google

 Growthcompany Info

 IG Index

 Interactive Investor

 Live Oil Price

 London Stock Exchange

 Money AM

 Motley Fool

 MSN Money

 Nasdaq

 New York Stock Exchange

 News of the World

 Shares mag

 Sky News

 Stockchallenge

 The Daily Mail

 The Daily Telegraph

 The Dailymash

 The Financial Times

 The Guardian

 The Indepenent

 The New York Times

 The Sun

 The Times Online

 The Wall Street Journal

 Wikipedia

 Yahoo

 You tube


Current Message Return to posts
From: Denc 🗡
And wrong of course…


The history of RNA drugs dates back to the early 1960s with the discovery of messenger RNA (mRNA), but it wasn't until the late 20th century that research on its therapeutic potential gained significant traction the first FDA-approved RNA drug, "Vitravene" (fomivirsen), was approved in 1998 for treating cytomegalovirus retinitis, marking a major milestone in the field however, the most recent surge in RNA drug development is attributed to the successful development of mRNA COVID-19 vaccines like Pfizer-BioNTech and Moderna, which brought widespread attention to the technology due to their rapid development and effectiveness during the pandemic.
Key points in the history of RNA drugs:
Early Discoveries (1960s):
The discovery of mRNA laid the foundation for RNA therapeutics research, with scientists beginning to explore its potential as a way to control protein production within cells.
Development of Delivery Systems (1970s-1990s):
Researchers started investigating methods to efficiently deliver RNA molecules into cells, leading to the development of lipid nanoparticles (LNPs) as a primary delivery system.
First FDA Approval (1998):
"Vitravene" (fomivirsen), an RNA-based drug targeting cytomegalovirus retinitis, became the first FDA-approved RNA therapeutic.
RNA Interference Discovery (Late 1990s):
The discovery of RNA interference (RNAi), a natural process where cells can silence specific genes using small RNA molecules, further fueled interest in RNA therapeutics.
Clinical Trials and Advancements (2000s-2010s):
Research expanded to explore RNA therapies for various diseases, including cancer, genetic disorders, and viral infections, with clinical trials investigating different RNA modalities like microRNAs (miRNAs) and small interfering RNAs (siRNAs).
COVID-19 Vaccine Breakthrough (2020-2021):
The development of mRNA vaccines against COVID-19 by Pfizer-BioNTech and Moderna marked a significant advancement in RNA therapeutics, demonstrating the potential of mRNA technology for large-scale vaccine production.


You must log in or register before you can post messages (you'll be returned to this page once logged in).



© 2000 sell on the internet (soti) ltd | feedback
www.the-millionaires-club.co.uk ... FTIR Investments of Geneva Place, Road Town, British Virgin Islands